Lab owner who defrauded Medicare to forfeit $187 million, Ferrari

Lab owner who defrauded Medicare to forfeit 7 million, Ferrari


Exhibit from court record: 2018 Red Ferrari Spider.

Source: U.S. DOJ

A Miami federal judge ordered a lab owner convicted of defrauding Medicare to forfeit more than $187 million worth of proceeds from the scam, including $30 million in cash, a 2018 Ferrari Spider and real estate, the Department of Justice said Wednesday.

The lab owner, Minal Patel of Atlanta, was sentenced in August to 27 years in prison for filing nearly $500 million in false claims to Medicare for sophisticated, and expensive, cancer genetic tests.

Medicare is the federally run program that provides health coverage to primarily older Americans.

The DOJ said Wednesday that the 44-year-old Patel conspired with telemedicine companies, call centers and patient brokers to convince Medicare beneficiaries to take the genetic tests through his company LabSolutions.

Telemedicine doctors robo-signed prescriptions for the tests even though they did not evaluate the patients and often did not even speak to them, according to the DOJ.

Medicare paid out more than $187 million in false claims for the tests.

In addition to the Ferrari, which retails for more than $300,000, Patel used proceeds to buy other luxury items, according to prosecutors.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More